BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Repros Therapeutics Reports Third Quarter 2017 Financial Results

  Net loss for the three month period ended September 30, 2017, was ($1.6) million or ($0.04) per share as compared to a net loss of ($4.2) million or ($0.17) per share for the same period in 2016.

  November 13, 2017

   · 

  7 min read
• Business

  ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2017

  Net sales from continuing operations were $5.7 million for the nine months ended September 30, 2017, as compared to net sales of $3.4 million for the nine months ended September 30, 2016.

  November 13, 2017

   · 

  10 min read
• Business

  Global Good and Motic Introduce Breakthrough AI-Powered Microscope to Fight Drug-Resistant Malaria

  This new collaboration will create and distribute the EasyScan GO*, a breakthrough AI-powered microscope to fight the spread of drug-resistant malaria and assist in case management.

  November 13, 2017

   · 

  4 min read
• 

  Deals

  Sawai Pharma Unloads 20% Stake in Its U.S. Subsidiary for $211M

  The transaction is expected to close by the end of March 2018.

  November 13, 2017

   · 

  3 min read
• Pharm Country

  Reliefband, Wearable Technology, Provides Relief to Those With Chronic Motion Sickness

  Reliefband Technologies is the leader in providing neuro-stimulation for the drug-free treatment of nausea.

  November 13, 2017

   · 

  2 min read
• Business

  ViewRay Inc. Reports Third Quarter 2017 Financial Results

  Total revenue of $12.2M in Q3 2017, up from $.04M in Q3 2016.

  November 13, 2017

   · 

  21 min read
• Business

  RXi Pharma and Gustave Roussy Announce Research Collaboration

  RXi Pharma and Gustave Roussy, a leading Comprehensive Cancer Centre in Europe, today announced that they have entered into a collaborative research agreement to evaluate the potential of RXi’s novel sd-rxRNA technology platform for use in cancer treatments.

  November 13, 2017

   · 

  4 min read
• Business

  Medicenna Reports Second Quarter Fiscal 2018 Financial Results

  Medicenna today reported financial results for the three and six months ended September 30, 2017.

  November 13, 2017

   · 

  12 min read
• Genetown

  Rodin Therapeutics Announces Award of Grant Support From The Michael J. Fox Foundation to Advance Novel Treatment Strategy for Parkinson’s Disease

  MJFF is supporting Rodin’s work through two rounds of grant funding, totaling approximately $600,000.

  November 13, 2017

   · 

  3 min read
• Trillium Therapeutics’ TTI-621 Program Featured at the Society for Immunotherapy of Cancer 32nd Annual Meeting

  Trillium Therapeutics announced today that new preclinical and clinical data from ongoing Phase 1 a/b trials for its CD47-blocking agent, TTI-621 (SIRPa-IgG1 Fc), were presented this weekend at the Society for Immunotherapy of Cancer 32nd Annual Meeting in National Harbor, Maryland USA.

  November 13, 2017

   · 

  6 min read